Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

Dr. Albritton is a resident physician and Dr. Kingdom is Assistant Professor in the Department of Otolaryngology at Emory University School of Medicine, Atlanta, Ga. Albritton FD, Kingdom TT.

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.

characterised by persistent inflammation of the nasal mucosa accompanied by benign growths, called nasal polyps.6,7 Nasal ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Paschal previously said that his absence was due to an annual scan he gets after dealing with skin cancer in 2018 and elaborated on Wednesday to say that he’s been out after having a benign mass ...

According to the American Cancer Society, colorectal cancer typically starts as a benign polyp (a small, abnormal growth) in the lining of the colon or rectum. Over time, some polyps can develop ...